IDIOPATHIC PULMONARY FIBROSIS (IPF)
Clinical trials for IDIOPATHIC PULMONARY FIBROSIS (IPF) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PULMONARY FIBROSIS (IPF) trials appear
Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for scarred lungs shows promise in early trial
Disease control CompletedThis study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal was to see if the drug is safe and tolerable over 12 weeks compared to a placebo. Resea…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tests arm strength as a window into IPF Patients' daily struggles
Knowledge-focused CompletedThis study looked at 21 adults with idiopathic pulmonary fibrosis (IPF) to see how a simple arm test (the 6-minute pegboard and ring test) relates to their exercise ability, fatigue, daily activities, and quality of life. Participants performed several physical tests, including w…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Muscle weakness linked to worse outcomes in lung disease patients
Knowledge-focused CompletedThis completed study looked at 60 people with idiopathic pulmonary fibrosis (IPF) to see how common muscle loss (sarcopenia) is and how it affects their quality of life and disease progression. Researchers measured muscle strength, walking speed, lung function, and used a questio…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:41 UTC